These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34538432)

  • 1. Plantar Psoriasis: A Review of the Literature.
    Romani M; Biela G; Farr K; Lazar R; Duval M; Trovillion V; Vlahovic TC
    Clin Podiatr Med Surg; 2021 Oct; 38(4):541-552. PubMed ID: 34538432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
    Raposo I; Torres T
    Am J Clin Dermatol; 2016 Aug; 17(4):349-58. PubMed ID: 27113059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
    Christophers E; Segaert S; Milligan G; Molta CT; Boggs R
    J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.
    Yosipovitch G; Tang MB
    Drugs Aging; 2002; 19(11):847-63. PubMed ID: 12428994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2016 Jul; 20(4):313-6. PubMed ID: 26848145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating patients with moderate-to-severe psoriasis vulgaris.
    Kessler TR
    JAAPA; 2022 Mar; 35(3):28-35. PubMed ID: 35120363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities.
    Chan SA; Hussain F; Lawson LG; Ormerod AD
    J Dermatolog Treat; 2013 Feb; 24(1):64-9. PubMed ID: 21797808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Apremilast Combination Therapies in the Treatment of Moderate to Severe Psoriasis.
    Ivanic MG; Thatiparthi A; Walia S; Liao W; Wu JJ
    J Drugs Dermatol; 2021 Aug; 20(8):837-843. PubMed ID: 34397197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apremilast in the treatment of palmoplantar pustulosis : A case series].
    Frischhut N; Ratzinger G
    Hautarzt; 2021 Mar; 72(3):252-256. PubMed ID: 32876701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics for the primary care physician: Review and treatment of psoriasis.
    Schadler ED; Ortel B; Mehlis SL
    Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
    Lambert J; Ghislain PD; Lambert J; Cauwe B; Van den Enden M
    J Dermatolog Treat; 2017 Aug; 28(5):394-400. PubMed ID: 27791446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis.
    Lebwohl M
    Ann Intern Med; 2018 Apr; 168(7):ITC49-ITC64. PubMed ID: 29610923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital Psoriasis: Impact on Quality of Life and Treatment Options.
    Kelly A; Ryan C
    Am J Clin Dermatol; 2019 Oct; 20(5):639-646. PubMed ID: 31313079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.
    Guenther L; Langley RG; Shear NH; Bissonnette R; Ho V; Lynde C; Murray E; Papp K; Poulin Y; Zip C
    J Cutan Med Surg; 2004; 8(5):321-37. PubMed ID: 15868311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Am J Clin Dermatol; 2021 May; 22(3):415-423. PubMed ID: 33712987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis phototherapy experience from a Lisbon unit: a still valid therapeutic approach in the 21st century.
    Carvalho R; Marques-Pinto G; Cardoso J
    Cutan Ocul Toxicol; 2013 Mar; 32(1):78-82. PubMed ID: 22250764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis and psoriatic arthritis treatment.
    Menter A
    Am J Manag Care; 2016 Jun; 22(8 Suppl):s225-37. PubMed ID: 27356194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective efficacy and safety study of UVB-TL01 phototherapy and PUVA therapy in palmoplantar psoriasis].
    Redon E; Bursztejn AC; Loos C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2010 Oct; 137(10):597-603. PubMed ID: 20932438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A
    J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of psoriasis.
    Al-Kudwah AJ; Feldman SR
    South Med J; 2009 Jun; 102(6):631-6. PubMed ID: 19434023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.